VAST VIEW Vir Biotechnology Names Suzanne Topalian to Board of Directors
Vir Biotechnology has appointed Suzanne Topalian to its board of directors, according to Investing.com.
Investing.com News
Vir Biotechnology announced the appointment of Suzanne Topalian to its board of directors, according to Investing.com. The addition was disclosed in a regulatory filing with the Securities and Exchange Commission.
Details about Topalian's background and the specific terms of her appointment were not included in the available filing information. Vir Biotechnology did not provide further comment beyond the disclosure, according to Investing.com.
Company Background
Vir Biotechnology is a biopharmaceutical company. No additional information about the company's current operations or strategic plans was included in the source material.
Sources: Investing.com News
More from Money
The bar is higher for software companies now that their stocks have been outperforming, but analysts identify some top picks whose results could shine through.
Heating-oil prices are at record highs. Washington’s answer is a loan you will never see and a pipeline that does not exist.